Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by AptarGroup, Inc.

< Previous 1 2 3 Next >
Aptar Reports Third Quarter 2025 Results
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
Aptar Named Among Top 100 of the ‘World’s Top Companies for Women 2025’ by Forbes
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
Aptar Increases Quarterly Dividend by Nearly 7% Signaling Continued Momentum and Long-Term Strength
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
Aptar Announces 2025 Investor Day
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
Aptar Reports Second Quarter 2025 Results
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
New Study Using Aptar’s Nasal Drug Delivery System Validates Insulin Nasal Spray to Deliver Alzheimer’s Drug Directly to the Brain
From AptarGroup, Inc.
Via Business Wire
Aptar Declares Quarterly Dividend
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
Aptar’s Dual-Active Material Science Technology Simultaneously Controls Moisture and Oxygen for Pharmaceutical Drugs and Medical Devices
From AptarGroup, Inc.
Via Business Wire
Aptar Named One of the World’s Most Sustainable Companies by TIME for Second Consecutive Year
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
Aptar to Participate in Upcoming Investor Conferences
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
Aptar Releases 2024 Corporate Sustainability Report
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
Aptar Digital Health Announces Licensing Agreement With AstraZeneca to Develop AI-Powered Screening Algorithms
From AptarGroup, Inc.
Via Business Wire
Aptar Reports First Quarter 2025 Results
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
Aptar Declares Quarterly Dividend
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
Aptar Announces Clinical Validation Study to Accelerate US FDA Approval of SmartTrack™ In-Vitro-in-Silico Platform for Pressurized Metered-Dose Inhalers
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
Aptar Named One of Barron’s 100 Most Sustainable U.S. Companies for the Seventh Consecutive Year
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
Aptar Recognized with Prestigious 'A' Score on the CDP Climate Change Assessment
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
Aptar Signs Renewable Energy Supply Agreement with Mercuria in Support of Sustainability Goals
From AptarGroup, Inc.
Via Business Wire
Aptar Reports Fourth Quarter and Annual 2024 Results
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
Aptar Declares Quarterly Dividend and Announces 2025 Annual Meeting Details
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
Aptar Named One of America’s Most Responsible Companies by Newsweek for the Sixth Consecutive Year
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
Aptar to Present at 43rd Annual J.P. Morgan Healthcare Conference on January 16, 2025
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
Aptar Named Among Top 50 of the ‘World’s Top Companies for Women 2024’ by Forbes
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
Aptar Reports Third Quarter 2024 Results
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
Aptar Awarded Federal Government Contract to Advance Novel Sterilization Technology for Medical Devices
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
Aptar Announces New $500 Million Share Repurchase Authorization and Declares Quarterly Dividend
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
Aptar’s N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Technology Program
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
Aptar’s Nasal Unidose System to Deliver neffy® (epinephrine nasal spray), the First and Only FDA-Approved Needle-Free Treatment for Type I Allergic Reactions, Including Anaphylaxis
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
Daniel Ackerman Named Aptar’s Chief Accounting Officer
From AptarGroup, Inc.
Via Business Wire
Tickers ATR
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.